Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2026-02-20 @ 3:51 PM
Study NCT ID:
NCT02283892
Status:
COMPLETED
Last Update Posted:
2016-02-23
First Post:
2014-11-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Respiratory Complaints Checklist Trial
Sponsor:
Hospital de Clinicas de Porto Alegre
Organization:
Study Overview
Official Title:
Randomized Clinical Trial of the Impact of a Respiratory Complaints Assessment Checklist on Resources Utilization and Clinical Outcomes in an Acute Evaluation Outpatient Clinic
Status:
COMPLETED
Status Verified Date:
2016-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RCC
Brief Summary:
This is a randomized clinical trial that evaluates the impact of using an internet-based checklist for systematic assessment of patients reporting respiratory complaints with the conventional assessment, without using the checklist.
Detailed Description:
This is a randomized clinical trial that evaluates the impact of using an internet-based checklist for systematic assessment of patients reporting respiratory complaints with the conventional assessment, without using the checklist.
Study setting: emergency department related acute evaluation outpatient clinic
Inclusion criteria: 18 years of age or older; patients presenting to the ED reporting cough or dyspnea;
Exclusion criteria: acute respiratory failure; SpO2 \< 92%; any signs of hemodynamic or respiratory instability; possible concurrent diagnosis requiring immediate assessment (e.g..: acute coronary syndrome or stroke; )
Primary outcome: need of reassessment in the ED or hospitalization within 1 month of index evaluation (intervention).
Secondary outcomes: number of complete blood counts ordered in the index evaluation; number of other diagnostic tests ordered in the index evaluation;
Randomization: block 1:1; stratified by gender and age (\>50 years old).
Masking will be appllied to: patients; outcome assessors; data analysts;
Study setting: emergency department related acute evaluation outpatient clinic
Inclusion criteria: 18 years of age or older; patients presenting to the ED reporting cough or dyspnea;
Exclusion criteria: acute respiratory failure; SpO2 \< 92%; any signs of hemodynamic or respiratory instability; possible concurrent diagnosis requiring immediate assessment (e.g..: acute coronary syndrome or stroke; )
Primary outcome: need of reassessment in the ED or hospitalization within 1 month of index evaluation (intervention).
Secondary outcomes: number of complete blood counts ordered in the index evaluation; number of other diagnostic tests ordered in the index evaluation;
Randomization: block 1:1; stratified by gender and age (\>50 years old).
Masking will be appllied to: patients; outcome assessors; data analysts;
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: